Core Drugs & Research Private Limited - Company Profile

It is a healthcare private limited company based in Indore, Madhya Pradesh, India, established in 2012.
2012 Indore, Madhya Pradesh, India Struck Off
Last Updated:
Access Report
About Core Drugs & Research Private Limited

Core Drugs & Research Private Limited, a struck off private limited company, was established on 19 October 2012 in Indore, Madhya Pradesh, India. Engaging in human health activities within the healthcare sector, it holds CIN: U85190MP2012PTC029411. Registered under ROC Roc Gwalior. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

Its leadership includes Pankaj Joshi (Director), Mohammad Suhaib Ali (Director), Ratan Mishra (Director). It is based at 206, Fortune Business Center 165, Rnt, Marg, Indore, Madhya Pradesh, 452001.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U85190MP2012PTC029411

  • Registration Number

    029411

  • Incorporation Date

    19 October 2012

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Gwalior

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 13 Year, 4 Months
Company report

Core Drugs & Research Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Core Drugs & Research Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Core Drugs & Research Private Limited?
Current Directors
Name Designation Appointment Date Status
Pankaj Joshi Director 19 Oct 2012 Current
Mohammad Suhaib Ali Director 19 Oct 2012 Current
Ratan Mishra Director 19 Oct 2012 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Core Drugs & Research.

Enhance accessibility to Core Drugs & Research's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Core Drugs & Research revenue growth over time
Core Drugs & Research profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Core Drugs & Research?

Unlock access to Core Drugs & Research's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Core Drugs & Research?

Unlock and access historical data on people associated with Core Drugs & Research, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Core Drugs & Research, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Core Drugs & Research's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Core Drugs & Research
Recent Activity within the Organization
  • Director Appointment

    Pankaj Joshi was appointed as a Director was appointed as a Director on 19 Oct 2012 & has been associated with this company since 13 years 4 months . was recorded as a recent event.

  • Director Appointment

    Mohammad Suhaib Ali was appointed as a Director was appointed as a Director on 19 Oct 2012 & has been associated with this company since 13 years 4 months . was recorded as a recent event.

  • Director Appointment

    Ratan Mishra was appointed as a Director was appointed as a Director on 19 Oct 2012 & has been associated with this company since 13 years 4 months . was recorded as a recent event.

  • Company Incorporation

    Progress on Core Drugs & Research Private Limited was registered on 19 Oct 2012 with Roc Gwalior & aged 13 years 4 months as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Core Drugs & Research Private Limited?

The CIN of Core Drugs & Research Private Limited is U85190MP2012PTC029411.

Where is Core Drugs & Research Private Limited headquartered?

Core Drugs & Research Private Limited is headquartered at 206, Fortune Business Center 165, Rnt, Marg, Indore, Madhya Pradesh, 452001.

When was Core Drugs & Research Private Limited incorporated?

Core Drugs & Research Private Limited was incorporated on 19 October 2012.

Who are the current directors of Core Drugs & Research Private Limited?

The current directors of Core Drugs & Research Private Limited are

What is the primary industry of Core Drugs & Research Private Limited?

The primary industry of Core Drugs & Research Private Limited is Healthcare.

Is Core Drugs & Research Private Limited a listed company?

Core Drugs & Research Private Limited is unlisted.

What is the capital structure of Core Drugs & Research Private Limited?

The authorized capital of Core Drugs & Research Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available